I'm looking for

Currently, a U.S. shortage of carboplatin and cisplatin exists that will likely last several months and possibly longer. Platinum drug shortages were first reported to the U.S. Food and Drug Administration (FDA) on February 10, 2023.

Below you’ll find valuable information including:

SGO Statement: Carboplatin and Cisplatin ShortagesFWC Statement: Carboplatin and Cisplatin ShortagesSGO, FWC, and GOG-F Communique: Shortages and Treating Cervical, Vulvar, and Vaginal Cancers
SGO, FWC, and GOG-F Communique: Considerations When Treating Gestational Trophoblastic Neoplasia in the Setting of a Methotrexate Shortage
SGO, FWC, and GOG-F Communique: Considerations When Treating Patients with Gynecologic Cancers on Clinical Trials in the Setting of Chemotherapy Shortages
SGO, FWC, and GOG-F Communique: Considerations When Treating Persons with Ovarian, Fallopian Tube, and Peritoneal Cancers in the Setting of Cisplatin and Carboplatin Shortages
SGO, FWC, and GOG-F Communique: Considerations When Treating Persons with Endometrial Malignancies in the Setting of Cisplatin and Carboplatin Shortages
NEW: SGO, FWC, and GOG-F Communique: CONSIDERATIONS WHEN TREATING PERSONS WITH GYNECOLOGIC CANCERS IN THE SETTING OF PEGYLATED LIPOSOMAL DOXORUBICIN SHORTAGES

National Media Coverage About Drug Shortage: 

These and other SGO member media mentions regarding the drug shortage are continuously being captured and included in this Twitter thread.

Are you a media organization seeking an SGO member comment on the drug shortage? E-mail Elizabeth Kix, MPH, APR with your request.

Are you an SGO member looking for talking points for media interviews focused on the drug shortage? E-mail Elizabeth Kix, MPH, APR for a copy.

 

Additional Resources
What You Can Do
  1. Endorse the rapid communications regarding treatment options to preserve drug supply and alternative chemotherapy drug guidelines if standard-of-care drugs are not available.
  2. Join us for upcoming webinars and round tables aimed at providing education and support to the cancer community, and share information with your extended networks.
  3. Work together to meet with and inform legislators. We need legislation for incentives for manufacturers and enhanced supply chain resilience, and to empower the FDA with more options to address drugs shortages. We also must explore the economic relationships between manufacturers and buyers. Click here to send a pre-written letter to your Members of Congress urging them to take action to mitigate and prevent chemotherapy drug shortages.
  4. Promote our efforts, alongside the efforts of other cancer organizations like OCRA, to amplify the message, conduct research on outcomes, and collaborate synergistically.
  5. Join the End Drug Shortages Alliance, which aims to enhance transparency, redundancy, quality, and production of medications to address supply shortages and improve patients’ access to vital drugs.
Endorsement of Guidelines
chemo-drug-shortage-lg

Drug Shortage Webinars

SGO Webinar: Chemotherapy Shortages: Root Causes, Regulatory Landscape, Legislative Process, and how the SGO is Navigating the Present and Future 

SGO Webinar: Optimizing Gynecologic Cancer Care in an Era Chemotherapy Drug Shortages

SGO Webinar: Navigating the Chemotherapy Crisis: Management Strategies and Tools for Patient-Provider Conversations

SGO Webinar: Chemotherapy Shortage: What Patients, Advocates and Survivors Need to Know

Gyn Cancer Chemotherapy Drug Shortages Group

SGO member community group discussing the recent carboplatin, cisplatin and methotrexate drug shortage and effective mitigation strategies.

Join the Discussion

webinar